Data and associated code to perform TCR-seq analysis in manuscript "Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s".
Contains The tabulated repertoires for all samples in the study – containing unique CDR3 clonotypes and their respective abundances – provided as output (*.tsv) by the ImmunoSEQ v2.0 (Adaptive Biotechnologies) proprietary processing pipeline.